Sign in

CIK 0001850119

  • Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
842040295
Phone
+1 215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,212
in 5 filings

Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-02 Russotti Gregory Chief Technology Officer Grant or award · Stock Option (right to buy) +175,000 175,000
2023-02-02 Borges Luis Chief Scientific Officer Grant or award +21,875 21,875
2023-02-02 Borges Luis Chief Scientific Officer Grant or award +21,875 43,750
2023-02-02 Borges Luis Chief Scientific Officer Grant or award · Stock Option (right to buy) +131,250 131,250
2023-02-02 Borges Luis Chief Scientific Officer Grant or award · Stock Option (right to buy) +131,250 131,250
2023-02-02 Farid Adrienne Chief Operations Officer Grant or award +21,875 96,093
2023-02-02 Farid Adrienne Chief Operations Officer Grant or award +21,875 117,968
2023-02-02 Farid Adrienne Chief Operations Officer Grant or award · Stock Option (right to buy) +131,250 131,250
2023-02-02 Farid Adrienne Chief Operations Officer Grant or award · Stock Option (right to buy) +131,250 131,250
2023-02-02 Diem Michael Craig Chief Business Officer Grant or award +21,875 101,363
2023-02-02 Diem Michael Craig Chief Business Officer Grant or award +21,875 123,238
2023-02-02 Diem Michael Craig Chief Business Officer Grant or award · Stock Option (right to buy) +131,250 131,250
2023-02-02 Diem Michael Craig Chief Business Officer Grant or award · Stock Option (right to buy) +131,250 131,250
2022-10-01 Quimi Daphne Director Grant or award · Stock Option (right to buy) +39,744 39,744
2022-10-01 Walbert Timothy P Director Grant or award · Stock Option (right to buy) +39,744 39,744
2022-08-09 Versant Venture Capital VI, L.P. 10% owner Sale −550,000 $13.03 $7.2M 11,816,814
2022-08-09 Versant Venture Capital VI, L.P. 10% owner Other disposition −364,800 11,452,014
2022-06-09 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +19,872 19,872
2022-06-09 Riva Alessandro Director Grant or award · Stock Option (right to buy) +19,872 19,872
2022-06-09 Blackwell Kimberly Director Grant or award · Stock Option (right to buy) +19,872 19,872

Page 10 of 12 · 233 trades